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Imported Human 
Fascioliasis, United 
Kingdom
To the Editor: We initiated en-
hanced surveillance for human fascio-
liasis after a reported increase in live-
stock cases in the United Kingdom. 
From January 1, 2008, through Janu-
ary 31, 2009, 11 human cases were 
confi rmed by the reference labora-
tory for England and Wales, compared 
with 6 cases during the preceding 10 
years. The Scottish reference labora-
tory detected no human cases during 
the study period.
Fascioliasis was defi ned as a 
positive Fasciola immunofl uorescent 
antibody test with a screening titer 
of 1:32 and either compatible clini-
cal or radiologic features consistent 
with the disease. We obtained clinical 
and radiologic information from the 
referring physician. Clinical features 
of both acute and chronic infection 
include fever, upper abdominal pain, 
malaise, eosinophilia, and impaired 
liver function; therefore, distinguish-
ing between the 2 phases can be diffi -
cult. Fifty percent of chronic infection 
is subclinical (1,2). Compatible radio-
logic features are capsular enhance-
ment with contrast, hypodense nodu-
lar areas, and low-density serpiginous 
lesions (2). Our analysis comprised 11 
cases (Table). Two patients were white 
British, both of whom had recently 
traveled to sub-Saharan Africa. Cases 
from the preceding 10 years diagnosed 
in our laboratory were all in persons 
with histories of travel to fascioliasis-
endemic areas. Therefore, these cases 
do not provide fi rm evidence of indig-
enous zoonotic transmission within 
England and Wales.
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Table. Characteristics of human fascioliasis case-patients during enhanced surveillance, United Kingdom, January 1, 2008–January
31, 2009* 
Case
no.
Age,
y/sex 
Country 
of origin 
Years since 
migration Other travel
Risk
factor
Clinical
features
Eosinophil
count,
x109/L) 
Abnormal
liver 
function Hepatic imaging IFAT†
1 45/F Yemen 7 Yemen 
regularly 
Khat
use
Abdominal
pain
8.4 Yes Mixed-density 
liver lesion (CT) 
1:128
2 44/M Somalia 16 Ethiopia
2007
Khat
use
Fever, 
abdominal
pain
3.4 Yes Serpiginous
lesion (MRI) 
1:64
3 34/F Ethiopia 3 S. Africa 
regularly 
Khat
use
Fever, 
abdominal
pain
11.4 No Heterogeneous 
lesion (USS) 
1:128
4 44/F Somalia 7 Somalia
2004,
Netherlands
Khat
use
Abdominal
pain
8.3 No Heterogeneous 
lesion (USS) 
1:128
5 54/F Somalia 21 (to 
Netherlands),
4 (to UK) 
None Khat
use
Anorexia 8.4 No Low-density 
lesion (CT) 
1:32
6 43/M Somalia 28 (to India), 
21 (to UK) 
None Khat
use
Fever 1.0 Yes Heterogeneous 
lesion (USS) 
1:128
7 28/F UK – Uganda
2007–2008
– Abdominal
pain,
hepatomegaly 
1.84 Yes Hepatomegaly 
with large mixed 
cystic and solid 
lesion (USS) 
1:512
8 67/M UK – Kenya 
2008, prior 
world travel 
– Malaise,
abdominal
pain
0.04 Yes Multiple
gallstones
(MRCP)
1:256
9 38/M Ethiopia 10 Ethiopia
2006
– Abdominal
pain, fever 
18.7 Yes Normal (USS, 
MRCP)
1:128
10 28/M Ethiopia Unknown Unknown – Fever, gram- 
negative
sepsis; new 
HIV diagnosis 
<0.04 Yes Lesion in 
hepatic vein 
1:64
11 47/F Somalia 16 (to 
Yemen), 
6 (to UK) 
Unknown Khat
use
Abdominal
pain, fever 
16.8 Yes Low-density 
lesion (CT) 
1:256
*IFAT, immunofluorescent antibody test; CT, computed tomography; MRI, magnetic resonance imaging; USS, ultrasound scan, MRCP, magnetic 
resonance cholangiopancreatography.  
†Titer of IFAT (screening titer 32). 
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Nine patients originated from 
Somalia, Ethiopia, or Yemen. Few 
cases have previously been reported 
from this area (3), although Ethiopian 
migrants have been shown to have 
an egg positivity of 0.4% on routine 
screening (4). Patients 5 and 6 had not 
returned to Africa for >20 years, sug-
gesting that they acquired their infec-
tion in Europe. Therefore, a risk factor 
may exist that is specifi c to this ethnic 
group within the United Kingdom.
Six cases were diagnosed at 1 
hospital. All 6 patients reported cur-
rent or past use of locally bought khat, 
a leaf chewed for its stimulant proper-
ties. It is imported fresh to the United 
Kingdom from Africa and is an ideal 
environment for the survival of Fas-
ciola cercariae. It is used most com-
monly by migrants from the Horn of 
Africa and Yemen and has been re-
ported in association with acute fas-
cioliasis in the United Kingdom (5). 
Use of imported khat may explain the 
apparently higher incidence of fascio-
liasis in this ethnic group residing in 
the United Kingdom.
Despite the described parallel rise 
in human and veterinary fascioliasis, 
none of these cases provide clear evi-
dence that recent human cases result-
ed from zoonotic transmission within 
the United Kingdom. Most cases oc-
curred in migrants from the Horn of 
Africa and Yemen, some of whom 
may have acquired Fasciola spp. in 
their country of origin; other cases 
appear likely to have been acquired 
in the United Kingdom, possibly due 
to use of imported khat. Physicians 
need a heightened awareness of fas-
cioliasis when investigating impaired 
liver function or abnormal abdomi-
nal imaging in migrants or travelers 
from high-risk areas.
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Gastroenteritis 
Outbreaks in 2 
Tourist Resorts, 
Dominican Republic
To the Editor: Noroviruses are 
an important cause of acute gastroen-
teritis, and outbreaks caused by these 
viruses have emerged as a major chal-
lenge to the healthcare, leisure, and 
tourism industries. The primary reason 
is their highly effi cient transmission 
among persons in semiclosed popula-
tions such as those in healthcare facili-
ties, hotels, and cruise ships. During 
an outbreak, primary cases result from 
exposure to a fecally contaminated 
vehicle (e.g., food or water), whereas 
secondary and tertiary cases among 
contacts of primary case-patients re-
sult from person-to-person transmis-
sion (1). Airborne and fomite trans-
mission also play a role in the virus 
spread during outbreaks (2). Trans-
mission through recreational water 
has also been described (3).
We investigated 2 outbreaks of no-
rovirus gastroenteritis in tourist resorts 
in the Dominican Republic in January 
2005. A total of 402 persons and 371 
persons at 2 resorts, 1 located in Punta 
Cana (attack rate 6.8%) and another 
in Puerto Plata (attack rate 6.2%), re-
spectively, reported symptoms of diar-
rhea, vomiting, headache, and fatigue. 
A total of 35 stools samples, 28 from 
Punta Cana and 7 from Puerto Plata, 
were negative for bacterial or parasitic 
pathogens. However, norovirus was 
confi rmed by the IDEIA norovirus 
immunoassay (DakoCytomation, Ely, 
UK) in 11 samples from Punta Cana 
and 7 samples from Puerto Plata.
Active measures to reduce noro-
virus transmission were adopted by 
the 2 resorts, including an increase 
in cleaning frequency and increase in 
concentration of chlorine used for sur-
face disinfection of public areas (1,000 
mg/L), kitchenware (200 mg/L for 15 
min), and fruits and vegetables (150 
mg/L for 15 min). Personnel involved 
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